Skip to main content
Clinical Trials/NCT05652452
NCT05652452CompletedNot Applicable

Neurodynamic Sliders Promote Flexibility in Tight Hamstring Syndrome

University Ghent0 sites50 target enrollmentStarted: January 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Primary Endpoint
Hamstring flexibility

Study Overview

Brief Summary

The goal of this study is to explore the intervention effect of home-based neurodynamic slider program on hamstring flexibility. Fifty physically active male subjects will be randomly assigned to either performing a neurodynamic sliding technique (3x20 reps) or a static stretching protocol (3x30") on a daily basis for a 6-week period. Hamstring flexibility will be assessed by means of the Straight Leg Raise at baseline, immediately after the intervention and after 4 weeks follow up.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •aged between 18-30yrs
  • •recreationally/competitively active
  • •limited hamstring flexibility (Tight Hamstring Syndrome) (SLR≤75°)

Exclusion Criteria

  • •a history of any musculotendinous hamstring injury in the previous year
  • •a history of neurological or orthopedic disorder affecting the lower extremities
  • •a history of lumbar disc herniation; or (4) a history of a cervical whiplash injury

Arms & Interventions

Neurodynamics

Experimental

Intervention: Neurodynamics (Other)

Static stretch

Active Comparator

Intervention: Static stretch (Other)

Outcomes

Primary Outcomes

Hamstring flexibility

Time Frame: 4 weeks after retention period

Straight leg raise by means of an app based goniometer

Hamstring flexibility

Time Frame: at Baseline

Straight leg raise by means of an app based goniometer

Hamstring flexibility

Time Frame: 6 weeks after intervention

Straight leg raise by means of an app based goniometer

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials